These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 24025057)
1. Amantadine, apomorphine and zolpidem in the treatment of disorders of consciousness. Gosseries O; Charland-Verville V; Thonnard M; Bodart O; Laureys S; Demertzi A Curr Pharm Des; 2014; 20(26):4167-84. PubMed ID: 24025057 [TBL] [Abstract][Full Text] [Related]
2. Pharmacology in Treatment of Patients with Disorders of Consciousness. Marino MH Phys Med Rehabil Clin N Am; 2024 Feb; 35(1):155-165. PubMed ID: 37993186 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of amantadine in children with impaired consciousness due to acquired brain injury: preliminary findings using a sparse-sampling technique. Vargus-Adams JN; McMahon MA; Michaud LJ; Bean J; Vinks AA PM R; 2010 Jan; 2(1):37-42. PubMed ID: 20129511 [TBL] [Abstract][Full Text] [Related]
4. Potential benefits of zolpidem in disorders of consciousness. Noormandi A; Shahrokhi M; Khalili H Expert Rev Clin Pharmacol; 2017 Sep; 10(9):983-992. PubMed ID: 28649875 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological modulation of the state of awareness in patients with disorders of consciousness: an overview. Mura E; Pistoia F; Sara M; Sacco S; Carolei A; Govoni S Curr Pharm Des; 2014; 20(26):4121-39. PubMed ID: 24025054 [TBL] [Abstract][Full Text] [Related]
6. Effects of amantadine in children with impaired consciousness caused by acquired brain injury: a pilot study. McMahon MA; Vargus-Adams JN; Michaud LJ; Bean J Am J Phys Med Rehabil; 2009 Jul; 88(7):525-32. PubMed ID: 19404190 [TBL] [Abstract][Full Text] [Related]
7. The Effectiveness of Zolpidem for the Treatment of Disorders of Consciousness. Tucker C; Sandhu K Neurocrit Care; 2016 Jun; 24(3):488-93. PubMed ID: 26718349 [TBL] [Abstract][Full Text] [Related]
8. [Clinical and electroencephalographic effects of amantadine sulfate (PK-Merz) on consciousness disorders due to the severe traumatic brain injury]. Cheliapina MV; Sharova EV; Zaĭtsev OS Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(5):24-9. PubMed ID: 21666589 [TBL] [Abstract][Full Text] [Related]
9. Does amantadine improve cognitive recovery in severe disorders of consciousness after aneurysmal subarachnoid hemorrhage? A double-blind placebo-controlled study. Gatto LAM; Demartini Z; Telles JPM; Figueiredo EG Clin Neurol Neurosurg; 2024 Feb; 237():108135. PubMed ID: 38330801 [TBL] [Abstract][Full Text] [Related]
10. Additive effect of cerebrolysin and amantadine on disorders of consciousness secondary to acquired brain injury: A retrospective case-control study. Lee S; Lee HH; Lee Y; Lee J J Rehabil Med; 2020 Feb; 52(2):jrm00025. PubMed ID: 32057086 [TBL] [Abstract][Full Text] [Related]
12. Effect of zolpidem in chronic disorders of consciousness: a prospective open-label study. Thonnard M; Gosseries O; Demertzi A; Lugo Z; Vanhaudenhuyse A; Bruno MA; Chatelle C; Thibaut A; Charland-Verville V; Habbal D; Schnakers C; Laureys S Funct Neurol; 2013; 28(4):259-64. PubMed ID: 24598393 [TBL] [Abstract][Full Text] [Related]
13. Disorders of consciousness after severe brain injury: therapeutic options. Schnakers C; Monti MM Curr Opin Neurol; 2017 Dec; 30(6):573-579. PubMed ID: 28901969 [TBL] [Abstract][Full Text] [Related]
14. Clinical and electroencephalographic on-off effect of amantadine in chronic non-traumatic minimally conscious state. Estraneo A; Pascarella A; Moretta P; Loreto V; Trojano L J Neurol; 2015 Jun; 262(6):1584-6. PubMed ID: 25957644 [No Abstract] [Full Text] [Related]
15. Awakenings and awareness recovery in disorders of consciousness: is there a role for drugs? Pistoia F; Mura E; Govoni S; Fini M; Sarà M CNS Drugs; 2010 Aug; 24(8):625-38. PubMed ID: 20658796 [TBL] [Abstract][Full Text] [Related]
16. Zolpidem and restoration of consciousness. Whyte J; Rajan R; Rosenbaum A; Katz D; Kalmar K; Seel R; Greenwald B; Zafonte R; Demarest D; Brunner R; Kaelin D Am J Phys Med Rehabil; 2014 Feb; 93(2):101-13. PubMed ID: 24434886 [TBL] [Abstract][Full Text] [Related]
17. Pharmacologic Therapies to Promote Recovery of Consciousness. Barra ME; Edlow BL; Brophy GM Semin Neurol; 2022 Jun; 42(3):335-347. PubMed ID: 36100228 [TBL] [Abstract][Full Text] [Related]
18. Treating Disorders of Consciousness With Apomorphine: Protocol for a Double-Blind Randomized Controlled Trial Using Multimodal Assessments. Sanz LRD; Lejeune N; Blandiaux S; Bonin E; Thibaut A; Stender J; Farber NM; Zafonte RD; Schiff ND; Laureys S; Gosseries O Front Neurol; 2019; 10():248. PubMed ID: 30941094 [No Abstract] [Full Text] [Related]
19. Incidence of clinically significant responses to zolpidem among patients with disorders of consciousness: a preliminary placebo controlled trial. Whyte J; Myers R Am J Phys Med Rehabil; 2009 May; 88(5):410-8. PubMed ID: 19620954 [TBL] [Abstract][Full Text] [Related]
20. Clinically significant response to zolpidem in disorders of consciousness secondary to anti-N-methyl-D-aspartate receptor encephalitis in a teenager: a case report. Appu M; Noetzel M Pediatr Neurol; 2014 Mar; 50(3):262-4. PubMed ID: 24417935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]